NERV
$5.50
Minerva Neuroscie
($.20)
(3.51%)
NERV
Earnings Whisper ®
N/A
1st Quarter March 2020
Consensus:  ($0.37)
Revenue:  $0.00 Mil
Monday
Jun 8
7:30 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when NERV reports earnings?
Beat
Meet
Miss

Where is NERV's stock price going from here?
Up
Flat
Down
Stock chart of NERV
Analysts
Summary of analysts' recommendations for NERV
Score
Grade
Pivots
Resistance
$6.12
$5.97
$5.74

$5.59

Support
$5.35
$5.20
$4.97
Tweet
Growth
Peers
Regeneron PharmaceuticalsBioMarin PharmaceuticalVertex PharmaceuticalsJohnson & JohnsonInterCeptZoetisBristol-Myers SquibbMylanUltragenyx PharmaceuticalAlkermes